The cost of production in cervical cytology: comparison of conventional and automated primary screening systems.
To thrive in a world of managed care and capitation, knowing the cost of production is critical, especially in cervical cytology. The relative costs of production for preparation and interpretation of cervical cytology for conventional manually read smears and a primary automated screening method were calculated in a university practice setting. The components were disposables, processing, screening, pathologist review, capital equipment, and facilities cost. The production cost for a conventional smear in our laboratory is $9.75, and the comparable production cost by a primary screening automated method would be $12.07, if it were approved for primary screening. Based on these calculations, an interactive automated method approved for primary screening would cost slightly more than conventional testing. Combinations of conventional and automated examinations (secondary screening systems) are not cost feasible unless the additional production expense can be passed through to the payers.
Bishop
J W
JW
Department of Pathology, Creighton University School of Medicine, Omaha, Nebraska 68131, USA.
D001331:Automation / Q000191:economics / Q000379:methods / Q000592:standards; D002584:Cervix Uteri / Q000473:pathology*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000191:economics* / Q000379:methods* / Q000592:standards; D002577:Uterine Cervical Diseases / Q000175:diagnosis / Q000191:economics* / Q000473:pathology*